Resultats de la cerca - Ivan M. Robbins

Refinar resultats
  1. 1
    Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation

    Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation per Anna R. Hemnes, Ivan M. Robbins

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Physical Activity Limitation as Measured by Accelerometry in Pulmonary Arterial Hypertension

    Physical Activity Limitation as Measured by Accelerometry in Pulmonary Arterial Hypertension per Meredith E. Pugh, Maciej S. Buchowski, Ivan M. Robbins, John H. Newman, Anna R. Hemnes

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Use of Pulmonary Arterial Hypertension–Approved Therapy in the Treatment of Non–Group 1 Pulmonary Hypertension at US Referral Centers

    Use of Pulmonary Arterial Hypertension–Approved Therapy in the Treatment of Non–Group 1 Pulmonary Hypertension at US Referral Centers per Aaron W. Trammell, Meredith E. Pugh, John H. Newman, Anna R. Hemnes, Ivan M. Robbins

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Causes of Pulmonary Hypertension in the Elderly

    Causes of Pulmonary Hypertension in the Elderly per Meredith E. Pugh, Lakshmi Sivarajan, Li Wang, Ivan M. Robbins, John H. Newman, Anna R. Hemnes

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Unrecognized glucose intolerance is common in pulmonary arterial hypertension

    Unrecognized glucose intolerance is common in pulmonary arterial hypertension per Meredith E. Pugh, Ivan M. Robbins, Todd W. Rice, James West, John H. Newman, Anna R. Hemnes

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Pathologic assessment of vasculopathies in pulmonary hypertension

    Pathologic assessment of vasculopathies in pulmonary hypertension per Giuseppe G. Pietra, Frédérique Capron, Susan Stewart, Ornella Leone, Marc Humbert, Ivan M. Robbins, Lynne Reid, Rubin M. Tuder

    Publicat 2004
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Impact of Diabetes on Survival and Right Ventricular Compensation in Pulmonary Arterial Hypertension

    Impact of Diabetes on Survival and Right Ventricular Compensation in Pulmonary Arterial Hypertension per Levi Benson, Evan L. Brittain, Meredith E. Pugh, Eric D. Austin, Kelly Fox, Lisa Wheeler, Ivan M. Robbins, Anna R. Hemnes

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation

    Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation per Ivan M. Robbins, Edward V. Colvin, Thomas P. Doyle, W. Evans Kemp, James E. Loyd, William McMahon, G. Neal Kay

    Publicat 1998
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension

    T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension per Eric D. Austin, Michael T. Rock, Claudio A. Mosse, Cindy L. Vnencak‐Jones, Sandra Yoder, Ivan M. Robbins, James E. Loyd, Barbara Meyrick

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension

    Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension per Paul Bresser, Peter F. Fedullo, William R. Auger, Richard N. Channick, Ivan M. Robbins, Kim M. Kerr, S. W. Jamieson, Lewis J. Rubin

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension

    High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension per Ivan M. Robbins, Anna R. Hemnes, Meredith E. Pugh, Evan L. Brittain, David Zhao, Robert N. Piana, Pete Fong, John H. Newman

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Association of the Metabolic Syndrome With Pulmonary Venous Hypertension

    Association of the Metabolic Syndrome With Pulmonary Venous Hypertension per Ivan M. Robbins, John H. Newman, Roger F. Johnson, Anna R. Hemnes, Richard D. Fremont, Robert N. Piana, David Zhao, Daniel W. Byrne

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension

    Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hyperten... per Raymond L. Benza, Werner Seeger, Vallerie V. McLaughlin, Richard N. Channick, Robert Voswinckel, Victor F. Tapson, Ivan M. Robbins, Horst Olschewski, Lewis J. Rubin

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease

    ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease per Christopher Lathen, Yu Zhang, Jennifer Chow, Martanday Singh, Grace Lin, Vishal Nigam, Yasser A. Ashraf, Jason X.‐J. Yuan, Ivan M. Robbins, Patricia A. Thistlethwaite

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2

    Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2 per Marc Humbert, Robyn J. Barst, Ivan M. Robbins, Richard N. Channick, Nazzareno Galiè, A. Boonstra, Leona J. Rubin, Evelyn M. Horn, A. Manes, G. Simonneau

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension

    Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension per Vallerie V. McLaughlin, Raymond L. Benza, Lewis J. Rubin, Richard N. Channick, Robert Voswinckel, Victor F. Tapson, Ivan M. Robbins, Horst Olschewski, Melvyn Rubenfire, Werner Seeger

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Longitudinal Analysis Casts Doubt on the Presence of Genetic Anticipation in Heritable Pulmonary Arterial Hypertension

    Longitudinal Analysis Casts Doubt on the Presence of Genetic Anticipation in Heritable Pulmonary Arterial Hypertension per Emma K. Larkin, John H. Newman, Eric D. Austin, Anna R. Hemnes, Lisa Wheeler, Ivan M. Robbins, James West, John A. Phillips, Rizwan Hamid, James E. Loyd

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

    Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension per Eric D. Austin, John A. Phillips, Joy D. Cogan, Rizwan Hamid, Chang Yu, Krista C. Stanton, Charles Phillips, Lisa Wheeler, Ivan M. Robbins, John H. Newman, James E. Loyd

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension

    Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension per Tufik R. Assad, Bradley A. Maron, Ivan M. Robbins, Meng Xu, Shi Huang, Frank E. Harrell, Eric Farber‐Eger, Quinn S. Wells, Gaurav Choudhary, Anna R. Hemnes, Evan L. Brittain

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension

    Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension per James P. Maloney, Robert S. Stearman, Todd Bull, David W. Calabrese, Megan L. Tripp-Addison, Marilee J. Wick, Ulrich Broeckel, Ivan M. Robbins, Lisa Wheeler, Joy D. Cogan, James E. Loyd

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: